LAMA2 gene analysis in a cohort of 26 congenital muscular dystrophy patients

Clinical Genetics

Volumn 74, Issue 6, 2008, Pages 502-512

  Oliveira, Jorge ^a   Santos, R ^a,b   Soares Silva, I ^a,c   Jorge, P ^a   Vieira, E ^a   Oliveira, M E ^a   Moreira, A ^d   Coelho, T ^e   Ferreira, J C ^f   Fonseca, M J ^g   Barbosa, C ^h   Prats, I ⁱ   Ariztegui M L ⁱ   Martins, M L ^j   Moreno, T ^k   Heinimann, K ^l   Barbot, C ^m   Pascual Pascual, S I ⁿ   Cabral, A ^o   Fineza, I ^p   Santos, M ^m   Bronze da Rocha, E ^b,q   more..

^a INSARJ   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF MINHO   (Portugal)

^d HOSPITAL DONA ESTEFÂNIA   (Portugal)

^e HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^f Centro Hospitalar de Lisboa Ocidental   (Portugal)

^g HOSPITAL GARCIA DE ORTA   (Portugal)

^h HOSPITAL PEDRO HISPANO   (Portugal)

ⁱ HOSPITAL DE CRUCES   (Spain)

^j Maternidade Dr Alfredo da Costa   (Portugal)

^k HOSPITAL DE SANTA MARIA   (Portugal)

^l UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^m HOSPITAL MARIA PIA   (Portugal)

ⁿ HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^o Centro de Reabilitação de Paralisia Cerebral de Coimbra   (Portugal)

^p CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^q UNIVERSITY OF PORTO   (Portugal)

more..

Author keywords

Congenital muscular dystrophy; Gross deletion; LAMA2; Laminin a2; MDC1A

Indexed keywords

COMPLEMENTARY DNA; LAMININ ALPHA2;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; DNA DETERMINATION; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE IDENTIFICATION; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC SCREENING; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MALE; MISSENSE MUTATION; MOLECULAR DYNAMICS; MUSCULAR DYSTROPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS;

EID: 56749104483     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2008.01068.x     Document Type: Article

References (23)

1. ToméFM, Evangelista T, Leclerc A et al. Congenital muscular dystrophy with merosin deficiency. C R Acad Sci III 1994: 317 (4): 351-357.
2. Mostacciuolo ML, Miorin M, Martinello F et al. Genetic epidemiology of congenital muscular dystrophy in a sample from north-east Italy. Hum Genet 1991: 97 (3): 277-279.
3. Miyagoe-Suzuki Y, Nakagawa M, Takeda S. Merosin and congenital muscular dystrophy. Microsc Res Tech 2000: 48 (3-4): 181-191.
4. Mendell JR, BouéDR, Martin PT. The congenital muscular dystrophies: Recent advances and molecular insights. Pediatr Dev Pathol 2006: 9 (6): 427-443.
5. Helbling-Leclerc A, Zhang X, Topaloglu H et al. Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet 1995: 11 (2): 216-218.
6. Zhang X, Vuolteenaho R, Tryggvason K. Structure of the human laminin alpha2-chain gene (LAMA2), which is affected in congenital muscular dystrophy. J Biol Chem 1999: 271: 27664-27669.
7. Aumailley M, Bruckner-Tuderman L, Carter WG et al. A simplified laminin nomenclature. Matrix Biol 2005: 24 (5): 326-332.
8. Leivo I, Engvall E. Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast, is expressed late in nerve and muscle development. Proc Natl Acad Sci U S A 1988: 85: 1544-1548.
9. Muntoni F, Voit T. The congenital muscular dystrophies in 2004: A century of exciting progress. Neuromuscul Disord 2004: 14 (10): 635-649.
10. Barresi R, Campbell KP. Dystroglycan: From biosynthesis to pathogenesis of human disease. J Cell Sci 2006: 119 (Pt 2): 199-207.
11. Pegoraro E, Marks H, Garcia CA et al. Laminin alpha2 muscular dystrophy: genotype/phenotype studies of 22 patients. Neurology 1998: 51 (1): 101-110.
12. Hayashi YK, Tezak Z, Momoi T et al. Massive muscle cell degeneration in the early stage of merosin-deficient congenital muscular dystrophy. Neuromuscul Disord 2001: 11 (4): 350-359.
13. Allamand V, Guicheney P. Merosin-deficient congenital muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for alpha2 chain of laminin). Eur J Hum Genet 2002: 10 (2): 91-94.
14. di Blasi C, Piga D, Brioschi P et al. LAMA2 gene analysis in congenital muscular dystrophy: New mutations, prenatal diagnosis, and founder effect. Arch Neurol 2005: 62 (10): 1582-1586.
15. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1998: 16 (3): 1215.
16. Shapiro MB, Senapathy P. RNA splice junctions of different classes of eukaryotes: Sequence statistics and functional implications in gene expression. Nucleic Acids Res 1987: 15 (17): 7155-7174.
17. Thompson JD, Gibson TJ, Plewniak F et al. The CLUSTAL_X windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997: 25 (24): 4876-4882.
18. Tezak Z, Prandini P, Boscaro M et al. Clinical and molecular study in congenital muscular dystrophy with partial laminin alpha 2 (LAMA2) deficiency. Hum Mutat 2003: 21 (2): 103-111.
19. van Deutekom JC, Janson AA, Ginjaar IB et al. Local dystrophin restoration with antisense oligonucleotide PRO051. N Engl J Med 2007: 357: 2677-2686.
20. Allamand V, Bidou L, Arakawa M et al. Drug-induced readthrough of premature stop codons leads to the stabilization of laminin α2 chain mRNA in CMD myotubes. J Gene Med 2008: 10: 217-224.
21. Uchikawa H, Fujii K, Kohno Y et al. U7 snRNA-mediated correction of aberrant splicing caused by activation of cryptic splice sites. J Hum Genet 2007: 52: 891-897.
22. Oliveira J, Soares-Silva I, Fokkema I et al. Novel synonymous substitution in POMGNT1 promotes exon skipping in a patient with congenital muscular dystrophy. J Hum Genet 2008: 53: 565-572.
23. den Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion. Hum Mutat 2000: 15: 7-12.